Lantern Pharma Files 8-K with Exhibits
Ticker: LTRN · Form: 8-K · Filed: 2026-04-10T08:00:30-04:00
Sentiment: neutral
Topics: disclosure, regulation-fd, filing
TL;DR
Lantern Pharma dropped an 8-K, likely with new info. Check the exhibits.
AI Summary
Lantern Pharma Inc. filed an 8-K on April 10, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). The filing includes various exhibits, such as the 8-K form itself and supplemental graphical information, indicating a disclosure event on April 9, 2026.
Why It Matters
This 8-K filing signals a material event or disclosure by Lantern Pharma, requiring immediate public notification to investors.
Risk Assessment
Risk Level: medium — 8-K filings often contain material information that can significantly impact a company's stock price, necessitating careful review.
Key Numbers
- 0001763950 — CIK Number (Identifies Lantern Pharma Inc. in SEC filings.)
- 0001493152-26-016047 — SEC Accession Number (Unique identifier for this specific 8-K filing.)
Key Players & Entities
- Lantern Pharma Inc. (company) — Filer of the 8-K
- 0001763950 (company) — CIK number for Lantern Pharma Inc.
- 2026-04-10 (date) — Filing date of the 8-K
- 2026-04-09 (date) — Period of report for the 8-K
FAQ
What specific information is disclosed under Regulation FD?
The filing does not detail the specific information disclosed under Item 7.01 (Regulation FD Disclosure), but it is presented as an exhibit (EX-99.1).
What is the purpose of the graphical exhibits (EX-99.1_001.jpg to EX-99.1_008.jpg)?
These graphical exhibits are part of the supplemental information provided with the 8-K filing, likely to visually represent data or findings related to the disclosure.
When was the period of report for this 8-K filing?
The period of report for this 8-K filing was April 9, 2026.
What are the mailing and business addresses for Lantern Pharma Inc.?
The mailing and business addresses for Lantern Pharma Inc. are both listed as 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201.
What SIC code is associated with Lantern Pharma Inc.?
The SIC code associated with Lantern Pharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
From the Filing
EDGAR Filing Documents for 0001493152-26-016047 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001493152-26-016047 Filing Date 2026-04-10 Accepted 2026-04-10 08:00:30 Documents 21 Period of Report 2026-04-09 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K form8-k.htm iXBRL 8-K 44032 2 EX-99.1 ex99-1.htm EX-99.1 6168 3 GRAPHIC ex99-1_001.jpg GRAPHIC 194997 4 GRAPHIC ex99-1_002.jpg GRAPHIC 199850 5 GRAPHIC ex99-1_003.jpg GRAPHIC 251026 6 GRAPHIC ex99-1_004.jpg GRAPHIC 263045 7 GRAPHIC ex99-1_005.jpg GRAPHIC 255063 8 GRAPHIC ex99-1_006.jpg GRAPHIC 234232 9 GRAPHIC ex99-1_007.jpg GRAPHIC 282304 10 GRAPHIC ex99-1_008.jpg GRAPHIC 268341 11 GRAPHIC ex99-1_009.jpg GRAPHIC 284030 Complete submission text file 0001493152-26-016047.txt 3291792 Data Files Seq Description Document Type Size 12 XBRL SCHEMA FILE ltrn-20260409.xsd EX-101.SCH 3029 13 XBRL LABEL FILE ltrn-20260409_lab.xml EX-101.LAB 34239 14 XBRL PRESENTATION FILE ltrn-20260409_pre.xml EX-101.PRE 22368 26 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3248 Mailing Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 Business Address 1920 MCKINNEY AVENUE 7TH FLOOR DALLAS TX 75201 972-277-1136 Lantern Pharma Inc. (Filer) CIK : 0001763950 (see all company filings) EIN. : 463973463 | State of Incorp.: TX | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39318 | Film No.: 26853211 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)